FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1822144788> ?p ?o ?g. }

• W1822144788 abstract "Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used medications for the treatment of both acute and chronic pain. Selective cyclooxygenase-2 (COX-2) inhibitors, such as celecoxib (Celebrex(®)), rofecoxib (Vioxx(®)), and diclofenac, have been among the most widely prescribed NSAIDs because they prevent the generation of prostaglandins involved in inflammation and pain, but avoid some of the gastrointestinal complications associated with less selective COX-1/COX-2 inhibitors. In 2004, rofecoxib (Vioxx(®)) was voluntarily withdrawn from the market because of adverse cardiovascular side effects. This led to an explosion of research into the cardiovascular effects of the 'coxibs', which revealed differential cardiovascular risk profiles among the members of this drug class. The differential risk profiles may relate to the tendency of some of the drugs to elevate blood pressure (BP). An important component of BP regulation is dependent on the contractile state of vascular smooth muscle cells (VSMCs), which is controlled to a large extent by the activities of KCNQ (Kv7 family) potassium channels and L-type calcium channels. Our recently published data indicate that celecoxib, but not rofecoxib or diclofenac, at therapeutically relevant concentrations, acts as a Kv7 potassium channel activator and a calcium channel blocker, causing relaxation of VSMCs and decreasing vascular tone. These vasorelaxant ion channel effects may account for the differential cardiovascular risk profiles among the different COX-2 inhibitors. We further speculate that these properties may be exploited for therapeutic benefit in the treatment of cardiovascular diseases or other medical conditions." @default.
• W1822144788 created "2016-06-24" @default.
• W1822144788 creator A5002531451 @default.
• W1822144788 creator A5067245641 @default.
• W1822144788 creator A5072621540 @default.
• W1822144788 creator A5080280713 @default.
• W1822144788 creator A5082414974 @default.
• W1822144788 date "2010-01-01" @default.
• W1822144788 modified "2023-09-23" @default.
• W1822144788 title "Novel Actions of Nonsteroidal Anti-Inflammatory Drugs on Vascular Ion Channels: Accounting for Cardiovascular Side Effects and Identifying New Therapeutic Applications." @default.
• W1822144788 cites W1533864205 @default.
• W1822144788 cites W1780627874 @default.
• W1822144788 cites W1973027891 @default.
• W1822144788 cites W1979543489 @default.
• W1822144788 cites W1980347216 @default.
• W1822144788 cites W2005677036 @default.
• W1822144788 cites W2006305093 @default.
• W1822144788 cites W2009065888 @default.
• W1822144788 cites W2011198932 @default.
• W1822144788 cites W2020820462 @default.
• W1822144788 cites W2047069083 @default.
• W1822144788 cites W2051826678 @default.
• W1822144788 cites W2053193368 @default.
• W1822144788 cites W2058346833 @default.
• W1822144788 cites W2064821447 @default.
• W1822144788 cites W2067516054 @default.
• W1822144788 cites W2081587319 @default.
• W1822144788 cites W2100631748 @default.
• W1822144788 cites W2129497878 @default.
• W1822144788 cites W2130648955 @default.
• W1822144788 cites W2130748648 @default.
• W1822144788 cites W2136679918 @default.
• W1822144788 cites W2148583712 @default.
• W1822144788 cites W2150820047 @default.
• W1822144788 cites W2155478429 @default.
• W1822144788 cites W2159911721 @default.
• W1822144788 cites W2160685542 @default.
• W1822144788 cites W2120627772 @default.
• W1822144788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2915785" @default.
• W1822144788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20689646" @default.
• W1822144788 hasPublicationYear "2010" @default.
• W1822144788 type Work @default.
• W1822144788 sameAs 1822144788 @default.
• W1822144788 citedByCount "12" @default.
• W1822144788 countsByYear W18221447882014 @default.
• W1822144788 countsByYear W18221447882015 @default.
• W1822144788 countsByYear W18221447882016 @default.
• W1822144788 countsByYear W18221447882017 @default.
• W1822144788 countsByYear W18221447882018 @default.
• W1822144788 countsByYear W18221447882020 @default.
• W1822144788 countsByYear W18221447882022 @default.
• W1822144788 crossrefType "journal-article" @default.
• W1822144788 hasAuthorship W1822144788A5002531451 @default.
• W1822144788 hasAuthorship W1822144788A5067245641 @default.
• W1822144788 hasAuthorship W1822144788A5072621540 @default.
• W1822144788 hasAuthorship W1822144788A5080280713 @default.
• W1822144788 hasAuthorship W1822144788A5082414974 @default.
• W1822144788 hasConcept C126322002 @default.
• W1822144788 hasConcept C181199279 @default.
• W1822144788 hasConcept C185592680 @default.
• W1822144788 hasConcept C197934379 @default.
• W1822144788 hasConcept C2776467144 @default.
• W1822144788 hasConcept C2778582115 @default.
• W1822144788 hasConcept C2779395532 @default.
• W1822144788 hasConcept C2779528491 @default.
• W1822144788 hasConcept C2779689624 @default.
• W1822144788 hasConcept C2779826273 @default.
• W1822144788 hasConcept C2992686903 @default.
• W1822144788 hasConcept C42219234 @default.
• W1822144788 hasConcept C519063684 @default.
• W1822144788 hasConcept C55493867 @default.
• W1822144788 hasConcept C71924100 @default.
• W1822144788 hasConcept C85520022 @default.
• W1822144788 hasConcept C98274493 @default.
• W1822144788 hasConceptScore W1822144788C126322002 @default.
• W1822144788 hasConceptScore W1822144788C181199279 @default.
• W1822144788 hasConceptScore W1822144788C185592680 @default.
• W1822144788 hasConceptScore W1822144788C197934379 @default.
• W1822144788 hasConceptScore W1822144788C2776467144 @default.
• W1822144788 hasConceptScore W1822144788C2778582115 @default.
• W1822144788 hasConceptScore W1822144788C2779395532 @default.
• W1822144788 hasConceptScore W1822144788C2779528491 @default.
• W1822144788 hasConceptScore W1822144788C2779689624 @default.
• W1822144788 hasConceptScore W1822144788C2779826273 @default.
• W1822144788 hasConceptScore W1822144788C2992686903 @default.
• W1822144788 hasConceptScore W1822144788C42219234 @default.
• W1822144788 hasConceptScore W1822144788C519063684 @default.
• W1822144788 hasConceptScore W1822144788C55493867 @default.
• W1822144788 hasConceptScore W1822144788C71924100 @default.
• W1822144788 hasConceptScore W1822144788C85520022 @default.
• W1822144788 hasConceptScore W1822144788C98274493 @default.
• W1822144788 hasLocation W18221447881 @default.
• W1822144788 hasOpenAccess W1822144788 @default.
• W1822144788 hasPrimaryLocation W18221447881 @default.
• W1822144788 hasRelatedWork W1568067728 @default.
• W1822144788 hasRelatedWork W1916932902 @default.
• W1822144788 hasRelatedWork W1971348323 @default.
• W1822144788 hasRelatedWork W1982935335 @default.
• W1822144788 hasRelatedWork W1986383551 @default.
• W1822144788 hasRelatedWork W2004428899 @default.

• next